SHIM
MRNA icon

Stone House Investment Management’s Moderna MRNA Stock Holding History

Stone House Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420 Buy
+6
New +$310 ﹤0.01% 1059
2024
Q4 		– Sell
-100
Closed -$6.68K – 237
2024
Q3 		$6.68K Sell
100
-24
-19% -$2.2K ﹤0.01% 248
2024
Q2 		$14.7K Sell
124
-76
-38% -$9.62K ﹤0.01% 197
2024
Q1 		$21.3K Sell
200
-95
-32% -$9.58K 0.01% 185
2023
Q4 		$29.3K Hold
295
– – 0.01% 106
2023
Q3 		$30.5K Buy
295
+61
+26% +$6.8K 0.01% 100
2023
Q2 		$28.4K Hold
234
– – 0.01% 102
2023
Q1 		$35.9K Buy
+234
New +$38.6K 0.01% 101

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Stone House Investment Management's MRNA Position: Q2 2026 in Review

Stone House Investment Management opened a new position in Moderna (MRNA) in Q2 2026: 6 shares worth $420. The stake represents ﹤0.01% of the portfolio and ranks #1059 among its holdings. This is a return to the name: Stone House Investment Management previously reported a position in MRNA as recently as Q3 2024.

Stone House Investment Management first reported a position in MRNA in Q1 2023 and has held it in 8 quarters since. The position peaked at $35.9K in Q1 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Stone House Investment Management held 6 shares of Moderna worth $420 as of Q2 2026.
  • Moderna was a new Stone House Investment Management position in Q2 2026.
  • Moderna made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #1059 holding.
  • Stone House Investment Management first reported a position in Moderna in Q1 2023 and has held it in 8 quarters since.
  • Stone House Investment Management's Moderna position peaked at $35.9K in Q1 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.